At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MentalPlus® for Assessment and Rehabilitation of Cognitive Functions After Remission of Symptoms of COVID-19
In Brief
A clinical study evaluating The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19 for Cognitive Impairment and 4 related conditions. Completed, enrolled 200 participants across 2 sites.
Detailed Summary
This study evaluates and rehabilitates the cognitive functions of attention, memory, visual perception, language, and executive by the mentalPlus® digital game of COVID-19 surviving patients after remission of symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Impairment, Covid19, Cognitive Dysfunction, Depression, Anxiety, Quality of Life
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartNov 2020
First PostedNov 2020
Primary CompletionDec 2020
Study CompletionDec 2023
TodayJul 2026
First PostedNov 17, 2020
Enrollment StartNov 8, 2020
Primary CompletionDec 29, 2020
Study CompletionDec 29, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.6 years ago
Interventions
The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19device
Cognitive assessment and rehabilitation will be carried out on volunteers who have healed from COVID-19.